Clinical Trial Update: An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating Stribild in ARV-naïve adults with HIV-2 infection in Dakar, Senegal. Results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-2 Infection

Drugs mentioned

• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)

Snippet

Sponsor: University of Washington | Conditions: HIV-2 Infection | Phase 4 | Status: COMPLETED | Results posted: 2018-05-08